Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Episode 79 – Pro Bono: Rewilding the Scottish Highlands Through Forest Restoration
|
Apr 16, 2024 |
Episode 78 – UK FinReg Focus Areas in 2024: ESG
|
Mar 08, 2024 |
Episode 77 – UK FinReg Focus Areas in 2024: Enforcement Against Individuals
|
Mar 05, 2024 |
Episode 76 – UK FinReg Focus Areas in 2024: Regulatory Divergence
|
Feb 29, 2024 |
Episode 75 – UK FinReg Focus Areas in 2024: Enforcement Against Firms
|
Feb 23, 2024 |
Episode 74 – UK FinReg Focus Areas in 2024: Conduct and Culture
|
Feb 19, 2024 |
Episode 73 – UK FinReg Focus Areas in 2024: Artificial Intelligence
|
Feb 08, 2024 |
Episode 72 – UK FinReg Focus Areas in 2024: The Edinburgh Reforms
|
Feb 02, 2024 |
Episode 71 – Drug Pricing: A Look Ahead at Trends for 2024
|
Feb 01, 2024 |
Episode 70 – UK FinReg Focus Areas in 2024: Investment Research
|
Jan 31, 2024 |
Episode 69 – UK FinReg Focus Areas in 2024: Retail Markets – Direction of Travel
|
Jan 26, 2024 |
Episode 68 – Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?
|
Jan 25, 2024 |
Episode 67 – PE Views: The Most Pressing Cybersecurity Considerations For Private Equity
|
Jan 23, 2024 |
Episode 66 – UK FinReg Focus Areas in 2024: Primary Markets Reform
|
Jan 19, 2024 |
Episode 65 – PE Views: How Can PE Sponsors Promote Transparency and Successful Fund Raise Amid ESG Scrutiny?
|
Dec 20, 2023 |
Episode 64 – Energy & Infrastructure: How Can Companies Avoid Greenwashing Allegations and ESG Litigation Risks?
|
Dec 18, 2023 |
Episode 63 – M&A Views: How Should Deal Teams Navigate a Global Crackdown on Restrictive Covenants?
|
Dec 14, 2023 |
Episode 62 – Has FDA Meaningfully Changed Its Restrictions on Off-Label Communications?
|
Dec 13, 2023 |
Episode 61 – Drug Pricing: New OIG Guidance Reaffirms the Seven Elements of an Effective Compliance Program
|
Dec 07, 2023 |
Episode 60 – PE Views: Is the CMA’s Focus on Roll-Up Transactions Here to Stay?
|
Nov 10, 2023 |
Episode 59 – SCOTUS Update: Perez v. Sturgis Secures a Supreme Court Win for Disability Rights
|
Nov 02, 2023 |
Episode 58 – FDI Developments: M&A Security Screening in Europe's Fragmented FDI Landscape
|
Oct 24, 2023 |
Episode 57 – Drug Pricing: What Trends Emerged from the 2023 Medicaid Drug Rebate Program Summit?
|
Oct 20, 2023 |
Episode 56 – M&A Views: Avoiding Buyer’s Remorse in M&A Deals
|
Sep 27, 2023 |
Episode 55 – Insurtech: What Should Startups Do After Receiving FCA Authorization?
|
Sep 21, 2023 |
Episode 54 – Drug Pricing: Focus on Best Price — CMS Proposed Rule, Inflation Reduction Act
|
Sep 15, 2023 |
Episode 53 – Energy & Infrastructure: Can Sustainable Finance Fuel the Energy Transition?
|
Aug 30, 2023 |
Episode 52 – Drug Pricing: Could a Single Reference Price Apply Across a Therapeutic Class?
|
Aug 21, 2023 |
Episode 51 – Drug Pricing: Final IRA Price Negotiation Guidance – How CMS Addressed the Part D/B Problem
|
Jul 31, 2023 |
Episode 50 – PE Views: Under New Reforms, Is the Customer Always Right?
|
Jul 14, 2023 |
Episode 49 – PE Views: Will Greenwashing Rain on the UK PE Parade?
|
Jun 20, 2023 |
Episode 48 – M&A Views: Will UK-Bound M&A Need to Come to US Terms?
|
Apr 27, 2023 |
Episode 47 – Real Estate Realities in Europe: Expensive Money and the Power of Private Equity
|
Apr 17, 2023 |
Episode 46 – PE Views: PE Must Strike the Right Balance With Unions
|
Mar 31, 2023 |
Episode 45 – Will Insurtech Reach New Heights in 2023?
|
Mar 08, 2023 |
Episode 44 – PE Views: Private Equity Looks to Share-Based Schemes to Incentivise Non-Managerial Staff
|
Jan 20, 2023 |
Episode 43 – Energy & Infrastructure: The Drivers and Opportunities of Asia’s Digital Infrastructure Boom
|
Nov 01, 2022 |
Episode 42 – PE Views: Has Rethinking Cannabis Sparked PE Interest?
|
Jul 11, 2022 |
Episode 41 – PE Views: Why Do Music Deals Sound So Attractive to PE?
|
Jun 09, 2022 |
Episode 40 – PE Views: Could PE Benefit From the Universal Adoption of “Super Senior” RCFs in Leveraged Financings?
|
Apr 28, 2022 |
Episode 39 – New FDA Commissioner Dr. Califf: What His Appointment Means for the Regulated Industry and What to Watch for in 2022
|
Feb 15, 2022 |
Episode 38 – PE Views: How are ESG Regulatory Reforms and Investor Focus Shaping the Market?
|
Feb 14, 2022 |
Episode 37 – Energy & Infrastructure: What’s Behind The Wave of ESG Shareholder Activism?
|
Jan 10, 2022 |
Episode 36 – Fintech Focus: The Year in Crypto – What Changed and What Comes Next in 2022?
|
Jan 04, 2022 |
Episode 35 – PE Views: Is Gaming the Next Level for Private Equity?
|
Dec 14, 2021 |
Episode 34 – Fintech Focus: What’s Next for Hong Kong and Singapore in 2022?
|
Dec 02, 2021 |
Episode 33 – PE Views: How is Creative Collateral Use Changing PE Finance Options?
|
Nov 19, 2021 |
Episode 32 – PE Views: Will UK IPOs with Dual Class Shares Surface New PE Opportunities?
|
Nov 10, 2021 |
Episode 31 – PE Views: How is Growth Equity Connecting PE and VC?
|
Nov 03, 2021 |
Episode 30 – PE Views: Has the Pandemic Increased Whistleblowing Risks?
|
Oct 07, 2021 |
Episode 29 – Energy & Infrastructure: What’s Driving the Oil & Gas Evolution in Europe?
|
Oct 01, 2021 |
Episode 28 – Energy & Infrastructure: What’s the View From Inside the DOE Loan Programs Office?
|
Aug 11, 2021 |
Episode 27 – Energy & Infrastructure: How Will EP4 Affect Projects in High-Income Countries?
|
Jul 07, 2021 |
Episode 26 – Energy & Infrastructure: Will the Market Sustain Its Interest in Sustainability-Linked Bonds?
|
May 25, 2021 |
Episode 25 – Fast Track to IPO: Why Are Series A Startups Snatching Topflight CFOs?
|
Apr 30, 2021 |
Episode 24 – Energy & Infrastructure: How Will the Biden Administration’s Goals Affect the Energy Transition?
|
Apr 14, 2021 |
Episode 23 – Energy & Infrastructure: Renewables Driving Change in the Investment Landscape
|
Apr 01, 2021 |
Episode 22 – PE Views: Foreign Investment Controls – Are We Seeing a More Nuanced Approach to Private Equity?
|
Mar 11, 2021 |
Episode 21 – Healthcare Tech: How Are Licensing Agreements Bridging the Industry Divide?
|
Mar 03, 2021 |
Episode 20 – Healthcare Tech: How Will the FDA Regulatory Framework Adapt to AI?
|
Feb 24, 2021 |
Episode 19 – Copyright & Brexit: How Will Article 15 of the EU Copyright Directive Affect Publishers and Platforms?
|
Feb 18, 2021 |
Episode 18 – Tech Trends: Has the Tide Turned for Transatlantic Data Transfers Post-Schrems II?
|
Feb 16, 2021 |
Episode 17 – Copyright & Brexit: Will the UK Copy the EU Directive or Develop Its Own Regime?
|
Jan 26, 2021 |
Episode 16 – Insolvency Reform: Spotting and Mitigating Future Risk in Supply Relationships
|
Jan 21, 2021 |
Episode 15 – Healthcare Tech: What Legal Pitfalls Should Tech Companies Avoid As They Jump Into Healthcare?
|
Jan 13, 2021 |
Episode 14 – Fintech Focus: Crypto in the Crosshairs – What Regulatory Themes Characterized 2020?
|
Jan 07, 2021 |
Episode 13 – Fintech Focus: How Did Singapore Solidify Its Position as a Leading Fintech Hub in 2020?
|
Dec 18, 2020 |
Episode 12 – Fintech Focus: Payments During the Pandemic – What Key Legal and Regulatory Themes Emerged During 2020?
|
Dec 16, 2020 |
Episode 11 – Restructuring in Asia: How Will Chinese Bond Defaults Resolve?
|
Dec 15, 2020 |
Episode 10 – PE Views: The Lipstick Effect — Why Are Beauty Deals Increasingly Attractive for Private Equity?
|
Dec 14, 2020 |
Episode 9 – Tech Trends: CCPA and the Next Wave of Data Privacy Regimes
|
Dec 09, 2020 |
Episode 8 – Corporate Culture: How to Attain Sustainable Change
|
Dec 02, 2020 |
Episode 7 – Brexit & Financial Services: Preparing for the End of the Transition Period
|
Nov 17, 2020 |
Episode 6 – Tech Trends: Tech M&A – How Has the Pandemic Changed the Market?
|
Oct 22, 2020 |
Episode 5 – Insolvency Reform: Termination on Ipso Facto of Supply Contracts
|
Oct 14, 2020 |
Episode 4 – The ABCs of ESG: How Are Companies Going Beyond the Basics?
|
Sep 23, 2020 |
Episode 3 – Tech Trends: AI is Here. Now, can we teach the robots ethics and legal compliance?
|
Jul 20, 2020 |
Episode 2 – Tech Trends: How Does Growth Debt Fuel Startups Between Equity Rounds?
|
Jun 29, 2020 |
Episode 1 – Tech Trends: IPO or Direct Listing?
|
Jun 18, 2020 |